Literature DB >> 25527863

Cord blood: a promising source of allogeneic natural killer cells for immunotherapy.

Hila Shaim1, Eric Yvon2.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25527863     DOI： 10.1016/j.jcyt.2014.12.001

Source DB:  PubMed          Journal:  Cytotherapy        ISSN： 1465-3249            Impact factor:   5.414


× No keyword cloud information.
  12 in total

1.  Zoledronate increases enrichment, activation and expansion of natural killer cells from umbilical cord blood.

Authors:  Zhijie Ma; Yunhong Wang; Huiyan Kang; Xiaoyun Wu
Journal:  Hum Cell       Date:  2018-06-13       Impact factor: 4.174

Review 2.  Engineering Natural Killer Cells for Cancer Immunotherapy.

Authors:  Katayoun Rezvani; Rayne Rouce; Enli Liu; Elizabeth Shpall
Journal:  Mol Ther       Date:  2017-06-28       Impact factor: 11.454

Review 3.  Revving up Natural Killer Cells and Cytokine-Induced Killer Cells Against Hematological Malignancies.

Authors:  Gianfranco Pittari; Perla Filippini; Giusy Gentilcore; Jean-Charles Grivel; Sergio Rutella
Journal:  Front Immunol       Date:  2015-05-13       Impact factor: 7.561

Review 4.  The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments.

Authors:  John P Veluchamy; Nina Kok; Hans J van der Vliet; Henk M W Verheul; Tanja D de Gruijl; Jan Spanholtz
Journal:  Front Immunol       Date:  2017-05-31       Impact factor: 7.561

5.  Patients Lacking a KIR-Ligand of HLA Group C1 or C2 Have a Better Outcome after Umbilical Cord Blood Transplantation.

Authors:  Carmen Martínez-Losada; Carmen Martín; Rafael Gonzalez; Bárbara Manzanares; Estefania García-Torres; Concha Herrera
Journal:  Front Immunol       Date:  2017-07-13       Impact factor: 7.561

Review 6.  Graft-versus-Leukemia Effect Following Hematopoietic Stem Cell Transplantation for Leukemia.

Authors:  Anne M Dickinson; Jean Norden; Shuang Li; Ilona Hromadnikova; Christoph Schmid; Helga Schmetzer; Hans Jochem-Kolb
Journal:  Front Immunol       Date:  2017-06-07       Impact factor: 7.561

Review 7.  Redirected Primary Human Chimeric Antigen Receptor Natural Killer Cells As an "Off-the-Shelf Immunotherapy" for Improvement in Cancer Treatment.

Authors:  Olaf Oberschmidt; Stephan Kloess; Ulrike Koehl
Journal:  Front Immunol       Date:  2017-06-09       Impact factor: 7.561

Review 8.  Renaissance of armored immune effector cells, CAR-NK cells, brings the higher hope for successful cancer therapy.

Authors:  Faroogh Marofi; Heshu Sulaiman Rahman; Lakshmi Thangavelu; Aleksey Dorofeev; Favian Bayas-Morejón; Naghmeh Shirafkan; Navid Shomali; Max Stanley Chartrand; Mostafa Jarahian; Ghasem Vahedi; Rebar N Mohammed; Somayeh Shahrokh; Morteza Akbari; Farhad Motavalli Khiavi
Journal:  Stem Cell Res Ther       Date:  2021-03-22       Impact factor: 6.832

Review 9.  The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer.

Authors:  Katayoun Rezvani; Rayne H Rouce
Journal:  Front Immunol       Date:  2015-11-17       Impact factor: 7.561

10.  A simple method for in vitro preparation of natural killer cells from cord blood.

Authors:  Yong Xu Mu; Yu Xia Zhao; Bing Yao Li; Hong Jing Bao; Hui Jiang; Xiao Lei Qi; Li Yun Bai; Yun Hong Wang; Zhi Jie Ma; Xiao Yun Wu
Journal:  BMC Biotechnol       Date:  2019-11-21       Impact factor: 2.563
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.